Analytical Data
-
Gene name
Synpr
- Application
-
Species
Rat
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P22831
-
Expression Region
1-265aa
-
Molecular Weight
35.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Synpr, or synaptic protein, is a crucial component in understanding the molecular mechanisms underlying synaptic functions and neuronal communication. Research into Synpr proteins has gained momentum due to their significant role in synapse development, plasticity, and overall brain functionality. Recent studies have highlighted the importance of Synpr in various neurological disorders, including schizophrenia, Alzheimer's disease, and autism spectrum disorders. The ability of Synpr to influence neurotransmitter release, receptor trafficking, and signaling pathways makes it a target of interest for developing therapeutic strategies. Moreover, advancements in recombinant protein technologies have enabled the study of Synpr structure and function, facilitating the exploration of its interactions with other synaptic proteins. As a result, Synpr research not only provides insights into fundamental neurobiological processes but also holds promise for innovative approaches in drug development for neuropsychiatric conditions. Understanding the dynamics of Synpr and its role in synaptic integrity could lead to breakthroughs in restoring neural function and creating effective treatment modalities for various brain disorders.
